Found 7 matching trials
Study Using WST11 in Patients With Localized Prostate Cancer
PHASE2The aim of this trial is to determine the optimal treatment conditions to a...
Location
Centre Hospitalier Universitaire (CHU)
European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up
N/AThis is an open observational extended follow-up study of patients original...
Location
Department of Urology-Tampere University Hospital-
Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer
PHASE3The aim of this study is to confirm the Efficacy,the Safety and the Quality...
Location
Hospital General Tlahuac
Study of WST11 in Patients With Localized Prostate Cancer
PHASE2The aim of this clinical study is to determine the optimal treatment condit...
Location
University Health Network-Princess Margaret Hospital
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
PHASE2Single center, single-arm, open-label, 60-month follow-up phase IIb clinica...
Status
Active Not Recruiting
Location
Memorial Sloan-Kettering Cancer Center
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
PHASE1The aim of this study is to determine the optimal treatment conditions (WST...
Location
UCLA - Jonsson Comprehensive Cancer Center
Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.
PHASE3The aims of this study are:
* to assess the impact of TOOKAD® Soluble-Vasc...
Location
Dept. of Urology-University Hospitals Leuven